A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy-Reference-Cited by-同舟云学术

A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy

Published:2018-03-21 Issue:15 Volume:24 Page:3583-3592
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Song Jiangdian,Shi Jingyun,Dong Di,Fang Mengjie,Zhong Wenzhao,Wang Kun,Wu Ning,Huang Yanqi,Liu Zhenyu,Cheng Yue,Gan Yuncui,Zhou Yongzhao,Zhou Ping,Chen Bojiang,Liang Changhong,Liu Zaiyi^ORCID,Li Weimin,Tian Jie

Funder

Natural Science Foundation of China

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical multi-dimensional prognostic nomogram for predicting the efficacy of immunotherapy in NSCLC;Scientific Reports;2024-09-13

2. Comprehensive Potential of Artificial Intelligence for Predicting PD-L1 Expression and EGFR Mutations in Lung Cancer: A Systematic Review and Meta-Analysis;Journal of Computer Assisted Tomography;2024-08-12

3. Research Progress of Artificial Intelligence in the Grading and Classification of Meningiomas;Academic Radiology;2024-08

4. Multi-sequence MRI-based radiomics: An objective method to diagnose early-stage osteonecrosis of the femoral head;European Journal of Radiology;2024-08

5. Brain metastasis magnetic resonance imaging-based deep learning for predicting epidermal growth factor receptor (EGFR) mutation and subtypes in metastatic non-small cell lung cancer;Quantitative Imaging in Medicine and Surgery;2024-07